10
Participants
Start Date
April 30, 2009
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
PF-04447943
35 mg tablet of PF-04447943 taken in the fed state in Period 1 followed a week later by administration of the same tablet and dose taken in the fasted state in Period 2
PF-04447943
35 mg tablet of PF-04447943 taken in the fasted state in Period 1 followed a week later by administration of the same tablet and dose in the fed state in Period 2.
Pfizer Investigational Site, New Haven
Lead Sponsor
Pfizer
INDUSTRY